Immunovant and Roivant report success in autoimmune drug’s Phase 3 trial Myasthenia gravis patients showed improvement with both low and high doses of batoclimab

https://www.statnews.com/2025/03/19/immunovant-roivant-batoclimab-myasthenia-gravis-autoimmune-trial-success/